![Kenneth Mills](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Kenneth Mills
Oprichter bij
REGENXBIO INC.
Vermogen: 5 M $ op 31-07-2026
Profiel
Kenneth T.
Mills is the founder of REGENXBIO, Inc., founded in 2008, serving as Chairman since 2024.
Mr. Mills is currently Chief Executive Officer & Director at Tagworks Pharmaceuticals BV since 2024.
Former positions include Director-Business Development at IGEN International, Inc. from 1997 to 2003, Chief Financial Officer & VP-Business Development at Meso Scale Diagnostics LLC from 2004 to 2006, and Partner at FoxKiser LLP from 2007 to 2015.
Education includes an undergraduate degree from the Massachusetts Institute of Technology, conferred in 1997.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
REGENXBIO, INC. 0,76% | 29-05-2026 | 495.925 ( 0,76% ) | 5 M $ | 31-07-2026 |
Actieve functies van Kenneth Mills
| Bedrijven | Functie | Begin |
|---|---|---|
| REGENXBIO INC. | Oprichter | 16-07-2008 |
Tagworks Pharmaceuticals BV
 Tagworks Pharmaceuticals BV BiotechnologyHealth Technology Develops biotechnology | Algemeen Directeur | 01-10-2024 |
Eerdere bekende functies van Kenneth Mills
| Bedrijven | Functie | Einde |
|---|---|---|
FOXKISER LLP
 FOXKISER LLP Miscellaneous Commercial ServicesCommercial Services Provides strategic advice and counseling services | Corporate Officer/Principal | 01-01-2015 |
Meso Scale Diagnostics LLC
 Meso Scale Diagnostics LLC Medical SpecialtiesHealth Technology Develops and markets solutions for multiplex biological assays | Financieel Directeur/CFO | 01-12-2006 |
IGEN International, Inc.
 IGEN International, Inc. Medical SpecialtiesHealth Technology Develops and markets biological testing systems that incorporate its proprietary electrochemiluminescence technology for used in drug discovery, diagnostic products development as well as food and environmental safety testing | Corporate Officer/Principal | 01-12-2003 |
Opleiding van Kenneth Mills
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
86
Eerstegraads connecties
6
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 6 |
|---|---|
REGENXBIO, Inc.
 REGENXBIO, Inc. Pharmaceuticals: MajorHealth Technology Develops gene therapy | Health Technology |
IGEN International, Inc.
IGEN International, Inc. Medical SpecialtiesHealth Technology Develops and markets biological testing systems that incorporate its proprietary electrochemiluminescence technology for used in drug discovery, diagnostic products development as well as food and environmental safety testing | Health Technology |
Massachusetts Institute of Technology
 Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
Meso Scale Diagnostics LLC
Meso Scale Diagnostics LLC Medical SpecialtiesHealth Technology Develops and markets solutions for multiplex biological assays | Health Technology |
FOXKISER LLP
FOXKISER LLP Miscellaneous Commercial ServicesCommercial Services Provides strategic advice and counseling services | Commercial Services |
Tagworks Pharmaceuticals BV
Tagworks Pharmaceuticals BV BiotechnologyHealth Technology Develops biotechnology | Health Technology |
